A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria

Human Reproduction

Volumn 30, Issue 2, 2015, Pages 315-322

  Busnelli, Andrea ^a,b   Papaleo, Enrico ^c   Del Prato, Diana ^c   La Vecchia, Irene ^a,b   Iachini, Eleonora ^c   Paffoni, Alessio ^a   Candiani, Massimo ^c   Somigliana, Edgardo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bologna criteria; Cost effectiveness; Poor responder

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; BIRTH RATE; BOLOGNA CRITERIA; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMBRYO TRANSFER; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GROSS NATIONAL PRODUCT; HUMAN; LIFE EXPECTANCY; LIVE BIRTH; MAJOR CLINICAL STUDY; PATIENT HISTORY OF CHEMOTHERAPY; POOR OVARIAN RESPONSE; PROGNOSTIC ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REFERENCE VALUE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; ADVERSE EFFECTS; CHILD PARENT RELATION; CLINICAL TRIAL; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG RESISTANCE; ECONOMICS; EPIDEMIOLOGY; EVALUATION STUDY; FAMILY SIZE; HEALTH CARE COST; INFERTILITY, FEMALE; ITALY; MALE; MULTICENTER STUDY; OVULATION INDUCTION; PRACTICE GUIDELINE; PROGNOSIS; PSYCHOLOGICAL MODEL; PSYCHOLOGY; STATISTICAL MODEL;

ADULT; BIRTH RATE; COHORT STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG RESISTANCE; FAMILY CHARACTERISTICS; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HEALTH CARE COSTS; HUMANS; INFERTILITY, FEMALE; ITALY; MALE; MODELS, ECONOMIC; MODELS, PSYCHOLOGICAL; OVULATION INDUCTION; PARENTING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84930741278     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu319     Document Type: Article

References (25)

1. Appleby J, Devlin N, Parkin D. NICE's cost effectiveness threshold. BMJ 2007;25:358-359.
2. Bollettino Ufficiale Regione Lombardia. Determinazioni in ordine alla gestione del servizio socio sanitario regionale per l'esercizio 2011. BollettinoUfficiale Regione Lombardia, N.50 S2. 2010. http://www.regione.lombardia.it/.
3. Busnelli A, Somigliana E, Benaglia L, Leonardi M, Ragni G, Fedele L. In vitro fertilization outcomes in treated hypothyroidism. Thyroid 2013;23:1319-1325.
4. Chambers GM, Adamson GD, Eijkemans MJ. Acceptable cost for the patient and society. Fertil Steril 2013;100:319-327.
5. Connolly M, Gallo F, Hoorens S, Ledger W. Assessing long-run economic benefits attributed to an IVF-conceived singleton based on projected lifetime net tax contributions in the UK. Hum Reprod 2009;24:626-632.
6. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005;43:5-14.
7. Ethics Committee of American Society for Reproductive Medicine. Fertility treatment when the prognosis is very poor or futile: a committee opinion. Fertil Steril 2012;98:e6-e9.
8. Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod 2014; 29:1842-1845.
9. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011; 26:1616-1624.
10. Kamble L, Gudi A, Shah A, Homburg R. Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF). Hum Fertil (Camb) 2011;14:230-245.
11. Ke H, Chen X, Liu YD, Ye DS, He YX, Chen SL. Cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the bologna criteria. J Huazhong Univ Sci Technolog Med Sci 2013;33:418-422.
12. NICE - National Collaborating Centre for Women's and Children's Health. Fertility: assessment and treatment for people with fertility problems (update): draft for stakeholder consultation-May 2012. www.nice.org.uk/nicemedia/live/12157/59278/59278.pdf.
13. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update 2012;18:1-11.
14. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2010(1):CD004379.
15. Papaleo E, Corti L, Vanni VS, Pagliardini L, Ottolina J, DeMichele F, LaMarca A, Viganò P, Candiani M. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles. Arch Gynecol Obstet 2014;290:169-176.
16. Papathanasiou A. Implementing the ESHRE'poor responder' criteria inresearch studies: methodological implications. Hum Reprod 2014;29:1835-1838.
17. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96:1058-1061.
18. Polyzos NP, Valachis A, Mauri D, Ioannidis JP. Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. CMAJ 2011;183:E337-E343.
19. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod 2012;27:3481-3486.
20. Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, Camus M, Tournaye H. Live birthrates in Bologna poor responders treated withovarian stimulation for IVF/ICSI. Reprod Biomed Online 2014;28:469-474.
21. Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, Arfuso V, Mignini-Renzini M, Candiani M, Paffoni A et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol 2012;10:114.
22. Scotland GS, McLernon D, Kurinczuk JJ, McNamee P, Harrild K, Lyall H, Rajkhowa M, Hamilton M, Bhattacharya S. Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost-utility of elective single versus double embryo transfer over a 20-year time horizon. BJOG 2011;118:1073-1083.
23. Somigliana E, Paffoni A, Busnelli A, Cardellicchio L, Leonardi M, Filippi F, Ragni G, Fedele L. IVF outcome in poor responders failing to produce viable embryos in the preceding cycle. Reprod Biomed Online 2013; 26:569-576.
24. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667-676.
25. Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod 2014;29:1839-1841.